Latest Administration News

DevEx Resources has identified multiple large-scale uranium exploration targets at its Nabarlek Project, supported by government co-funding and advancing ground surveys. Meanwhile, soil geochemistry testing is underway at Murphy West, signalling sustained exploration momentum.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

eMetals Limited has completed initial soil sampling at its Busia Gold Project in Uganda, revealing a significant 300-meter-wide gold-in-soil anomaly. The company continues to advance exploration efforts across its Ugandan assets while negotiating land access for further work.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Megado Minerals has completed the acquisition of an 80% stake in the Iberian Copper Project in Northern Spain, backed by overwhelming shareholder support. The company is advancing geological mapping and preparing for drilling later this year, while also raising A$780,000 through an institutional placement.

Invictus Energy is preparing to drill the high-impact Musuma-1 exploration well outside its Mukuyu discovery area, while securing National Project Status for its Cabora Bassa Project in Zimbabwe.

Bod Science Limited reports a dramatic reduction in half-year losses alongside revenue growth driven by a strategic shift to THC products. The company remains under a Deed of Company Arrangement with key corporate actions pending shareholder approval.